Increased microRNA-146a/b, TRAF6 gene and decreased IRAK1 gene expressions in the peripheral mononuclear cells of patients with Sjögren's syndrome

Immunology Letters

Volumn 141, Issue 2, 2012, Pages 165-168

  Zilahi, Erika ^a   Tarr, Tünde ^a   Papp, Gábor ^a   Griger, Zoltán ^a   Sipka, Sándor ^a   Zeher, Margit ^a  

^a UNIVERSITY OF DEBRECEN   (Hungary)

Author keywords

IRAK1; MicroRNA 146a; Sj gren's syndrome; TRAF6

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 1; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 4; MICRORNA; MICRORNA 146A; MICRORNA 146B; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE OVEREXPRESSION; GENE PRODUCT; GENE TARGETING; GENETIC REGULATION; HUMAN; HUMAN CELL; IRAK1 GENE; IRAK4 GENE; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SJOEGREN SYNDROME; TRAF6 GENE; TRANSCRIPTION REGULATION;

AGED; BIOLOGICAL MARKERS; FEMALE; GENE EXPRESSION REGULATION; HUMANS; IMMUNITY, INNATE; INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASES; LEUKOCYTES, MONONUCLEAR; MALE; MICRORNAS; MIDDLE AGED; SIGNAL TRANSDUCTION; SJOGREN'S SYNDROME; TNF RECEPTOR-ASSOCIATED FACTOR 6;

EID: 84855934791     PISSN: 01652478     EISSN: 18790542     Source Type: Journal    
DOI: 10.1016/j.imlet.2011.09.006     Document Type: Article

References (29)

1. Chua J.H., Armugam A., Jeyaseelan K. MicroRNAs: biogenesis, function and applications. Curr Opin Mol Ther 2009, 11(2):189-199.
2. Du C., Liu C., Kang J., Zhao G., Ye Z., Huang S., et al. MicroRNA miR-326 regulates t(H)-17 differentiation and is associated with the pathogenesis of multiple sclerosis. Nat Immunol 2009, 10(12):1259-1359.
3. Nakasa T., Miyaki S., Okubo A., Hashimoto A., Nishida K., Ochi M., et al. Expression of microRNA-146 in rheumatoid arthritis synovial tissue. Arthritis Rheum 2008, 58(5):1284-1292.
4. Pauley K.M., Satoh M., Chan A.L., Bubb M.R., Reeves W.H., Chan E.K. Upregulated miR-146a expression in peripheral blood mononuclear cells from rheumatoid arthritis patients. Arthritis Res Ther 2008, 10(4):R101.
5. Tang Y., Luo X., Cui H., Ni X., Yuan M., Guo Y., et al. MicroRNA-146A contributes to abnormal activation of the type I interferon pathway in human lupus by targeting the key signaling proteins. Arthritis Rheum 2009, 60(4):1065-1075.
6. Alevizos I., Bajracharya S.D., Alexander S., Turner R.J., Illei G.G. MicroRNA profiling of minor salivary glands identifies disease and inflammation biomarkers in Sjögren's syndrome patients. Arthitis Rheum 2009, 21:465-470.
7. Alevizos I., Illei G.G. MicroRNAs in Sjögren's syndrome as a prototypic autoimmune disease. Autoimmun Rev 2010, 9:618-621.
8. Kapsogeorgou E.K., Gourzi V.C., Manoussakis N., Moutsopoulos M., Tzioufas A.G. Cellular microRNAs (miRNAs) and Sjögren's syndrome: candidate regulators of autoimmune response and autoantigen expression. J Autoimmun 2011, (May):1-7. [Epub ahead of print]. http://www.elsevier.com/locate/jautimm.
9. Boldin M.P., Taganov K.D., Rao D.S., Yang L., Zhao J.L., Kalwani M., et al. miR-146 is a significant brake on autoimmunity, myeloproliferation and cancer in mice. J Exp Med 2011, 208:1189-1201.
10. Taganov K.D., Boldin M.P., Chang K.J., Baltimore D. NF-kappaB dependent induction of microRNA-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc Natl Acad Sci USA 2006, 103:12481-12486.
11. Lu L.F., Boldin M.P., Chaudhry A., Lin L.L., Taganov K.D., Hanada T., et al. Function of miR-146a in controlling Treg cell-mediated regulation of Th1 responses. Cell 2010, 142:914-929.
12. Belver L., Papavasiliou F.N., Ramiro R. MicroRNA control of lymphocyte differentiation and function. Curr Opin Immunol 2011, 23:368-373.
13. Beyaert R. SHP works a double sfift to control TLR signalling. Nat Imunol 2011, 725-727.
14. He H., Jazdzewski K., Li W., Liyanarachchi S., Nagy R., Volina S., et al. The role of microRNA genes in papillary thyreoid carcinoma. Proc Natl Acad Sci USA 2005, 102:19075-19080.
15. Li L., Chen X.P., Li Y.J. MicroRNA-146a and human disease. Scand J Immunol 2010, 71:227-231.
16. Vitali C., Bombardieri S., Jonsson R., et al. European study group on classification criteria for Sjögren's syndrome, classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European consensus group. Ann Rheum Dis 2002, 61:554-558.
17. Jensen L.E., Muzio M., Mantovani A., Whitehead A.S. IL-1 signaling cascade in liver cells and the involvement of a soluble form of the IL-1 receptor accessory protein. J Immunol 2000, 164:5277-5286.
18. Ye H., Arron J.R., Lamothe B., et al. Distinct molecular mechanism for initiating TRAF6 signalling. Nature 2002, 418:443-447.
19. Bhaumik D., Scott G.K., Schokrpur S., Patil C.K., Campisi J., Benz C.C. Expression of microRNA-146 suppresses NF-kappaB activity with reduction of metastatic potential in breast cancer cells. Oncogene 2008, 27:5643-5647.
20. Williams A.E., Perry M.M., Moschos S.A., Larner-Svensson H.M., Lindsay M.A. Role of miRNA-146a in the regulation of the innate immune response and cancer. Biochem Soc Trans 2008, 36:1211-1215.
21. Jacob C.O., Zhu J., Armstrong D.L., Yan M., Han J., Zhou X.J., et al. Identification of IRAK1 as a risk gene with critical role in the pathogenesis of systemic lupus erythematosus. Proc Natl Acad Sci USA 2009, 106:6256-6261.
22. Bíró Z., Griger E., Kiss E., Papp H., Aleksza M., Kovács I., et al. Abnormal cell specific expressions of certain protein kinase C isoensymes in peripheral mononuclear cells of patients with systemic lupus erythematosus: effect of corticosteroid application. Scand J Immunol 2004, 60:421-428. et.
23. Zhang P., Chan J., Dragoi A.M., Gong X., Ivanov S., Li Z.W., et al. Activation of IKK by thymosin alpha1 requires the TRAF6 signalling pathway. EMBO Rep 2005, 6(June (6)):531-537.
24. Tada Y., Nagasawa K., Yamauchi Y., Tsukamoto H., Niho Y. A defect in the protein kinase C system in T cells from patients with systemic lupus erythematosus. Clin Immunol Immunopathol 1991, 60:220-231.
25. Kyttaris V.C., Krishnan S., Tsokos G.S. System biology in systemic lupus erythematosus: integrating genes, biology and immune finction. Autoimmunity 2006, 39:705-709.
26. Cui J.G., Li Y.Y., Thao Y., Battacharjee S., Lukiw W.J. Differential regulation of interleukin-1 receptor associated kinase-1 (IRAK-1) and IRAK2 by microRNA-146a and NF-kappaB in stressed human astroglial cells and in Alzheimer disease. J Biol Chem 2010, 285:38951-38960.
27. Chatzikyriakidou A., Voulgari P.V., Georgiu I., Drosos A.A. A polymorphism in3'UTR of interleukin-1 receptor associated kinase (IRAK1), a target gene of miR-146a, is associated with rheumatoid arthritis susceptibility. Joint Bone Spine 2010, 77:411-413.
28. Lappalainen M., Paavola-Saki P., Halme L., Turunen U., Heliö T., Farkkila M., Kontula K., et al. Screening of tumor necrosis factor receptor associated factor 6 as a candidate gene for inflammatory bowel disease. Scand J Gastroenterol 2006, 41:424-429.
29. Potter C., Eyre S., Cope A., Worthington J., Barton A. Investigation of association between of the TRAF family genes and RA susceptibility. Ann Rheum Dis 2007, 66:1322-1326.